Nonselective Beta-Blockers May Reduce Prostate Cancer Recurrence Risk
Use of a nonselective beta-blocker at the time of radical prostatectomy (RP) may reduce the risk for prostate cancer recurrence, investigators suggest. In a study of 11,117 treatment-naïve patients with prostate cancer underwent RP in…